logo

For the Inventor, By the Inventor

Newton, MA, United States of America

Rachel E Meyers

This inventor holds 62 USPTO granted patents and 13 published patent applications and 4 EPO patents, primarily in RNAi Therapeutics (CPC class C12N). Top assignees: Millennium Pharmaceuticals Limited, Alnylam Pharmaceuticals, Inc., The University of Texas System. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel E Meyers. Retrieved from https://idiyas.com/inventor/rachel-e-meyers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 62 

% Patents Active = 24.2

 

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 475(Granted Patents)

Forward Citations (Not Self Cited) = 461(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Cambridge, MA (US) (2010)
  • Newton, MA (US) (2002 - 2015)

Company Filing History:

goldMedal54 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
silverMedal8 out of 465 
 
Alnylam Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 5,633 
 
The University of Texas System
 patents
where one patent can have more than one assignee

Years Active: 2002-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
RNAi Modulation
RSV Infection
Human Protein Kinases
Influenza Gene Expression
Human Transferase
Phospholipase C
Ubiquitin Protease
Dehydrogenase
Nucleic Acid Sequences
Aminotransferase
Protease Family
Novel Kinase
62 patents (USPTO):Explore Patents
1. 9127277 - Methods and compositions for prevention or treatment of RSV infection (2015-09-08),
2. 8859750 - RNAi modulation of RSV and therapeutic uses thereof (2014-10-14),
3. 8410073 - Methods and compositions for prevention or treatment of RSV infection (2013-04-02),
4. 8263572 - RNAi modulation of RSV and therapeutic uses thereof (2012-09-11),
5. 8252915 - Human transferase family members and uses thereof (2012-08-28),
6. 8227188 - Enhancement of influenza gene expression (2012-07-24),
7. 7981869 - RNAi modulation of RSV and therapeutic uses thereof (2011-07-19),
8. 7879989 - 16836, A human phospholipase C family member, nucleic acids and uses thereof (2011-02-01),
9. 7867729 - 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor (2011-01-11),
10. 7799898 - Human transferase family members and uses thereof (2010-09-21),
11. 7732182 - 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor (2010-06-08),
12. 7705120 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer (2010-04-27),
13. 7704711 - Human protein kinases and uses therefor (2010-04-27),
14. 7696316 - 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor (2010-04-13),
15. 7611879 - 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor (2009-11-03),

Title: Rachel E Meyers - Pioneering Inventor from Newton, MA

Introduction: Rachel E Meyers is a trailblazing inventor hailing from Newton, MA, known for her innovative contributions to various fields.

Latest Patents: Rachel E Meyers holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Rachel E Meyers has had a successful career marked by groundbreaking inventions that have had a significant impact on society.

Collaborations: Throughout her career, Rachel E Meyers has collaborated with leading research institutions, universities, and companies to bring her inventions to life, fostering a culture of innovation and collaboration.

Conclusion: Rachel E Meyers continues to inspire aspiring inventors with her creativity, determination, and commitment to pushing the boundaries of what is possible in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…